Contact
searchSearch
HMP Global
LINC
News
HMP Global’s Leipzig Interventional Course (LINC) Announces 20th Anniversary Congress in January 2025
07/22/2024
LINC, the world’s premier interdisciplinary live course for vascular and endovascular teams, announced that its annual meeting is shifting from summer to winter, with its 20th anniversary Congress in January 2025.
LINC, the world’s premier interdisciplinary live course for vascular and endovascular teams, announced that its annual meeting is shifting from summer to winter, with its 20th anniversary Congress in January 2025.
LINC, the world’s premier...
07/22/2024
Vascular Disease Management
Dr Lookstein
LINC 2024
The Future of Treatment of Venous Thromboembolism Is Single-session/On-table Therapy
05/30/2024

Robert Lookstein, MD
Icahn School of Medicine at Mount Sinai, New York, New York

Robert Lookstein, MD Icahn School of ...
The future of venous thrombosis treatment was tackled in a VIVA@LINC session on Wednesday afternoon by Robert Lookstein, MD, Professor of Radiology and Surgery at the Icahn School of Medicine at Mount Sinai in New York City.
The future of venous thrombosis treatment was tackled in a VIVA@LINC session on Wednesday afternoon by Robert Lookstein, MD, Professor of Radiology and Surgery at the Icahn School of Medicine at Mount Sinai in New York City.
The future of venous thrombosis...
05/30/2024
Vascular Disease Management
Dr Tsilimparis
LINC 2024
Physician-modified Endografts on Trial
05/30/2024

Nikolaos Tsilimparis, MD
University Hospital of Munich, Germany

Nikolaos Tsilimparis, MD University H...
The case for physician-modified endografts in urgent settings was made by Nikolaos Tsilimparis, who spoke about an important multicenter trial on physician-modified endografts in complex aortic surgery.
The case for physician-modified endografts in urgent settings was made by Nikolaos Tsilimparis, who spoke about an important multicenter trial on physician-modified endografts in complex aortic surgery.
The case for physician-modified...
05/30/2024
Vascular Disease Management
Dr Nakama
LINC 2024
BEST-CLI, BASIL-2 and Beyond: Bridging the Gap Between Our Daily Clinical Practice and Research Realities
05/30/2024

Tatsuya Nakama, MD
Tokyo Bay Medical Center, Japan

Tatsuya Nakama, MD Tokyo Bay Medical ...
The clinical realities of big trials such as BEST-CLI and BASIL-2 were dissected by Dr. Tatsuya Nakama in a session that explored strategic visions for the future of below-the-knee interventions.
The clinical realities of big trials such as BEST-CLI and BASIL-2 were dissected by Dr. Tatsuya Nakama in a session that explored strategic visions for the future of below-the-knee interventions.
The clinical realities of big...
05/30/2024
Vascular Disease Management
Dr Ducasse
LINC 2024
12-month LUMIFOLLOW Results Mimic Real Life for DCB
05/30/2024

Eric Ducasse, MD
University of Bordeaux, France

Eric Ducasse, MD University of Bordea...
The latest results from the LUMIFOLLOW trial—a prospective, multicenter, consecutive, post-market study of the Luminor drug-eluting balloon (DCB; iVascular) in the treatment of femoropopliteal lesions—was discussed by Eric Ducasse, Professor...
The latest results from the LUMIFOLLOW trial—a prospective, multicenter, consecutive, post-market study of the Luminor drug-eluting balloon (DCB; iVascular) in the treatment of femoropopliteal lesions—was discussed by Eric Ducasse, Professor...
The latest results from the...
05/30/2024
Vascular Disease Management
Dr Langhoff
LINC 2024
Atherectomy for Infrainguinal PAD?
05/29/2024

Ralf Langhoff
Sankt Gertrauden-Krankenhaus, Berlin, Germany

Ralf Langhoff Sankt Gertrauden-Kranke...
Preliminary results from a systematic literature review on the use of atherectomy for infrainguinal peripheral artery disease were presented on Tuesday by angiologist Ralf Langhoff.
Preliminary results from a systematic literature review on the use of atherectomy for infrainguinal peripheral artery disease were presented on Tuesday by angiologist Ralf Langhoff.
Preliminary results from a...
05/29/2024
Vascular Disease Management
Dr Wittig
LINC 2024
New RCT Hopes to ‘CRACK-IT’ With Aggressive Vessel Prep in Heavily Calcified Fempop Lesions
05/29/2024

Tim Wittig, MD
University Hospital Leipzig, Germany

Tim Wittig, MD University Hospital Le...
An introduction to a new trial focused on aggressive vessel preparation took center stage on Wednesday as part of a ‘last frontiers’ session tackling severely calcified lesions. Tim Wittig detailed the CRACK-IT trial.
An introduction to a new trial focused on aggressive vessel preparation took center stage on Wednesday as part of a ‘last frontiers’ session tackling severely calcified lesions. Tim Wittig detailed the CRACK-IT trial.
An introduction to a new trial...
05/29/2024
Vascular Disease Management
Dr Schlager
LINC 2024
Quality of Life PROMinance Vital in Venous Interventions
05/29/2024

Oliver Schlager, MD
Medical University of Vienna, Austria

Oliver Schlager, MD Medical Universit...
Quality of life assessments were explored in detail on Tuesday morning by Oliver Schlager, who talked about the severity of venous insufficiency and post-thrombotic syndrome, which are typically assessed by the Villalta scale.
Quality of life assessments were explored in detail on Tuesday morning by Oliver Schlager, who talked about the severity of venous insufficiency and post-thrombotic syndrome, which are typically assessed by the Villalta scale.
Quality of life assessments were...
05/29/2024
Vascular Disease Management
Dr Schneider
LINC 2024
20 Years of Innovation: How Much Progress Have We Made With Interventional Treatment of Lower Limb Arterial Disease?
05/29/2024

Peter A. Schneider, MD
University of California, San Francisco

Peter A. Schneider, MD University of ...
“Concepts, techniques, tools, goals of care—all of that’s changed dramatically with regards to catheter-based treatments for lower extremity revascularization over the last 20 years,” said Dr. Peter Schneider.
“Concepts, techniques, tools, goals of care—all of that’s changed dramatically with regards to catheter-based treatments for lower extremity revascularization over the last 20 years,” said Dr. Peter Schneider.
“Concepts, techniques, tools,...
05/29/2024
Vascular Disease Management
Dr Patrone
LINC 2024
How Robots Will Re-define the Standards of Endovascular Interventions
05/28/2024

Lorenzo Patrone, MD
West London Vascular and Interventional Centre, London, UK

Lorenzo Patrone, MD West London Vascu...
At LINC, Dr Patrone discussed a new project based on the Sentante, a fully robotic teleoperated system for endovascular interventions that has been created by UAB Inovatyvi Medicina (Kaunas, Lithuania).
At LINC, Dr Patrone discussed a new project based on the Sentante, a fully robotic teleoperated system for endovascular interventions that has been created by UAB Inovatyvi Medicina (Kaunas, Lithuania).
At LINC, Dr Patrone discussed a...
05/28/2024
Vascular Disease Management
Dr Manuela Konert
LINC 2024
Can Post-thrombotic Syndrome Be Prevented?
05/28/2024

Manuela Konert, MD
University Hospital Leipzig, Germany

Manuela Konert, MD University Hospita...
The case for mechanical thrombectomy as a means to eliminate post-thrombotic syndrome (PTS) was discussed today by Manuela Konert, a consultant interventionalist and head of the venous centre at University Hospital Leipzig, Germany. 
The case for mechanical thrombectomy as a means to eliminate post-thrombotic syndrome (PTS) was discussed today by Manuela Konert, a consultant interventionalist and head of the venous centre at University Hospital Leipzig, Germany. 
The case for mechanical...
05/28/2024
Vascular Disease Management
Dr Suai
LINC 2024
AVF Treatment Leaves a Great IMPRESSION
05/28/2024

Tan Chieh Suai
Singapore General Hospital, Singapore

Tan Chieh Suai Singapore General Hosp...
The first data from a randomized controlled trial looking into the treatment of arteriovenous fistula (AVF) stenosis was announced today by Dr Tan Chieh Suai from Singapore General Hospital.
The first data from a randomized controlled trial looking into the treatment of arteriovenous fistula (AVF) stenosis was announced today by Dr Tan Chieh Suai from Singapore General Hospital.
The first data from a randomized...
05/28/2024
Vascular Disease Management
Michael Lichtenberg MD
LINC 2024
Aspirex Could Push Through to New Era in Mechanical Thrombectomy
05/28/2024

Michael Lichtenberg, MD
Arnsberg Vascular Clinic, Arnsberg, Germany

Michael Lichtenberg, MD Arnsberg Vasc...
A study of a mechanical thrombectomy device in the treatment of acute venous occlusions was given a 24-month update today by Michael Lichtenberg, an interventional radiologist and head of the Arnsberg Vascular Clinic.
A study of a mechanical thrombectomy device in the treatment of acute venous occlusions was given a 24-month update today by Michael Lichtenberg, an interventional radiologist and head of the Arnsberg Vascular Clinic.
A study of a mechanical...
05/28/2024
Vascular Disease Management
Houman Jalaie, MD, PhD & Mohammad E. Barbati, MD, FEBVS
LINC 2023
Decoding Chronic Venous Obstruction: Introducing a New Classification System for Predicting Treatment Outcomes
06/08/2023
This classification system can help identify optimal candidates for intervention, tailor treatment approaches, and inform patients about potential outcomes.
This classification system can help identify optimal candidates for intervention, tailor treatment approaches, and inform patients about potential outcomes.
This classification system can...
06/08/2023
Vascular Disease Management
Dr de Vries
LINC 2023
Home Monitoring of Tissue Perfusion Post-PTA Predicts Clinical Outcome of CLTI Patients
06/08/2023
Home monitoring will change the way we conduct outpatient monitoring. In every European country, there is a real shortage of nursing staff and outpatient clinic time – every little bit helps.
Home monitoring will change the way we conduct outpatient monitoring. In every European country, there is a real shortage of nursing staff and outpatient clinic time – every little bit helps.
Home monitoring will change the...
06/08/2023
Vascular Disease Management
Dr Montero-Baker
LINC 2023
PROMISE-ing Updates for Percutaneous Deep Vein Arterialization
06/08/2023
Transcatheter arterialization of the deep veins is safe and effective, and offers a potential new treatment option for patients facing amputation.
Transcatheter arterialization of the deep veins is safe and effective, and offers a potential new treatment option for patients facing amputation.
Transcatheter arterialization of...
06/08/2023
Vascular Disease Management
Dr Donas
LINC 2023
EnChEVAR: A Force for Standardization
06/08/2023
Rather than a ‘bailout’ procedure for the chimney technique, EnChEVAR could become a standardized, therapeutic, complementary option.
Rather than a ‘bailout’ procedure for the chimney technique, EnChEVAR could become a standardized, therapeutic, complementary option.
Rather than a ‘bailout’...
06/08/2023
Vascular Disease Management
Dr Ferraresi
LINC 2023
Deep Venous Arterialization: How Does It Work?
06/07/2023
Although revascularization options have substantially improved in recent years, ~20% of CLTI patients are still considered not suitable for any type of traditional revascularization.
Although revascularization options have substantially improved in recent years, ~20% of CLTI patients are still considered not suitable for any type of traditional revascularization.
Although revascularization...
06/07/2023
Vascular Disease Management
Dr Verhagen
LINC 2023
Trial Set to ADVANCE Knowledge in Sac Regression
06/07/2023
An important head-to-head RCT of 2 leading aortic stent-graft systems were discussed on Wednesday by Hence Verhagen, Chief of Vascular Surgery at Erasmus University Medical Center in Rotterdam, the Netherlands.
An important head-to-head RCT of 2 leading aortic stent-graft systems were discussed on Wednesday by Hence Verhagen, Chief of Vascular Surgery at Erasmus University Medical Center in Rotterdam, the Netherlands.
An important head-to-head RCT of...
06/07/2023
Vascular Disease Management
Dr Desai
LINC 2023
Thrombectomy for DVT: Tips on Patient Selection and Procedure
06/07/2023
The questions of when and how to employ thrombectomy for DVT were addressed by Dr Kush Desai during a VIVA@LINC session on Wednesday.
The questions of when and how to employ thrombectomy for DVT were addressed by Dr Kush Desai during a VIVA@LINC session on Wednesday.
The questions of when and how to...
06/07/2023
Vascular Disease Management
Dr Parikh
LINC 2023
Looking Toward a Shift From Paclitaxel to Limus Agents
06/07/2023
Dr Parikh outlines the basis of the interest in limus devices as an alternative to paclitaxel. In his opinion, the paclitaxel mortality controversy is not a major factor here.
Dr Parikh outlines the basis of the interest in limus devices as an alternative to paclitaxel. In his opinion, the paclitaxel mortality controversy is not a major factor here.
Dr Parikh outlines the basis of...
06/07/2023
Vascular Disease Management
BeGraft
News
Another Milestone Achieved – Bentley Sold Its 300,000th BeGraft
06/07/2023

Bentley Press Release 

Bentley Press Release 
Bentley, a leading manufacturer of balloon expandable covered stents, announced at the annual LINC meeting in Leipzig, Germany, that it has reached an important milestone having sold the 300,000th BeGraft.
Bentley, a leading manufacturer of balloon expandable covered stents, announced at the annual LINC meeting in Leipzig, Germany, that it has reached an important milestone having sold the 300,000th BeGraft.
Bentley, a leading manufacturer...
06/07/2023
Vascular Disease Management
Dr Almoaiqel
LINC 2023
Varicose Veins: Updates in Thermal and Non-thermal Ablation
06/06/2023
Dr Almoaiqel provides insight into his Tuesday afternoon session at LINC 2023.
Dr Almoaiqel provides insight into his Tuesday afternoon session at LINC 2023.
Dr Almoaiqel provides insight...
06/06/2023
Vascular Disease Management
Dr Erwin Blessing
LINC 2023
Intravascular Lithotripsy Lives Up to Its Promise
06/06/2023
Dr Erwin Blessing spoke to LINC Today to discuss the relevant research and give his take on how intravascular lithotripsy fits into the toolbox for vessel preparation.
Dr Erwin Blessing spoke to LINC Today to discuss the relevant research and give his take on how intravascular lithotripsy fits into the toolbox for vessel preparation.
Dr Erwin Blessing spoke to LINC...
06/06/2023
Vascular Disease Management
Dr Gary Ansel
LINC 2023
FlowTriever Embolectomy for Acute Pulmonary Embolism
06/06/2023
Dr Gary Ansel discusses the FlowTriever System (Inari Medical), the first mechanical thrombectomy device indicated for the treatment of pulmonary embolism.
Dr Gary Ansel discusses the FlowTriever System (Inari Medical), the first mechanical thrombectomy device indicated for the treatment of pulmonary embolism.
Dr Gary Ansel discusses the...
06/06/2023
Vascular Disease Management
Dr Brodmann
LINC 2023
A Little ELEGANCE in the Study of Under-Represented Patients
06/06/2023
First-time data from an important study of the real-world treatment of lesions in the peripheral vasculature was previewed this afternoon by Marianne Brodmann, Head of the Division of Angiology at the Medical University of Graz, Austria.
First-time data from an important study of the real-world treatment of lesions in the peripheral vasculature was previewed this afternoon by Marianne Brodmann, Head of the Division of Angiology at the Medical University of Graz, Austria.
First-time data from an...
06/06/2023
Vascular Disease Management
Biotronik Oscar
News
BIOTRONIK Launches Oscar Multifunctional Peripheral Catheter at LINC 2023
06/05/2023
BUELACH, Switzerland - June 05, 2023. BIOTRONIK is pleased to announce the limited release of its Oscar® (One Solution: Cross. Adjust. Restore) multifunctional peripheral catheter and start of promotional activities at LINC, the Leipzig...
BUELACH, Switzerland - June 05, 2023. BIOTRONIK is pleased to announce the limited release of its Oscar® (One Solution: Cross. Adjust. Restore) multifunctional peripheral catheter and start of promotional activities at LINC, the Leipzig...
BUELACH, Switzerland - June 05,...
06/05/2023
Vascular Disease Management
Dr. Beckman
LINC 2022
The Cost of CLTI: How Many Amputations Occur Each Year and What Is the Cost to the Patient and Society?
08/09/2022
At the VIVA@LINC session of "Big Picture Trends in Chronic Limb-Threatening Ischemia," Joshua Beckman, MD, from Boston, Massachusetts, presented the cost implications–in every sense–of amputation.
At the VIVA@LINC session of "Big Picture Trends in Chronic Limb-Threatening Ischemia," Joshua Beckman, MD, from Boston, Massachusetts, presented the cost implications–in every sense–of amputation.
At the VIVA@LINC session of "Big...
08/09/2022
Vascular Disease Management
Strategy
First-Time Data Release/LINC 2022
Treating Common Femoral Artery Steno-occlusive Lesions With an Endovascular Approach Using DA + DCB: 3-year Follow-up in 75 Patients
06/12/2022
Dr. Angelo Cioppa, from Montevergine Clinic in Mercogliano, Italy, shared the results of a study that looked at combining the advantages of open surgery with endovascular surgery.
Dr. Angelo Cioppa, from Montevergine Clinic in Mercogliano, Italy, shared the results of a study that looked at combining the advantages of open surgery with endovascular surgery.
Dr. Angelo Cioppa, from...
06/12/2022
Vascular Disease Management
Outcomes
First-Time Data Release/LINC 2022
Predictors of Drug-Coated Balloon Efficacy in Femoropopliteal Intervention: Insights From a Patient-Level Pooled Analysis
06/11/2022
Prakash Krishnan, MD, from Mount Sinai Health System in New York, shared the results of a study that evaluated the predictors of drug-coated balloon outcomes in a large, rigorous dataset with the use of core labs and CEC adjudication
Prakash Krishnan, MD, from Mount Sinai Health System in New York, shared the results of a study that evaluated the predictors of drug-coated balloon outcomes in a large, rigorous dataset with the use of core labs and CEC adjudication
Prakash Krishnan, MD, from Mount...
06/11/2022
Vascular Disease Management
Dr. Eleshra
LINC 2022
Single-Center Results of Endovascular Repair in Patients With Marfan Syndrome
06/10/2022
Ahmed Eleshra, MD, a vascular surgeon from Mansoura, Egypt, provides data on single-center results of endovascular repair for patients with Marfan Syndrome.
Ahmed Eleshra, MD, a vascular surgeon from Mansoura, Egypt, provides data on single-center results of endovascular repair for patients with Marfan Syndrome.
Ahmed Eleshra, MD, a vascular...
06/10/2022
Vascular Disease Management
Dr. Branzan
LINC 2022
The Role of 3D Printing in the Treatment of Urgent Complex Aortic Pathologies
06/10/2022
Daniela Branzan, MD describes her work in 3D printing of custom-made stent grafts.
Daniela Branzan, MD describes her work in 3D printing of custom-made stent grafts.
Daniela Branzan, MD describes...
06/10/2022
Vascular Disease Management
Dr. Azizzadeh
LINC 2022
Endovascular Rescue for Blunt Trauma Aortic Injury
06/10/2022
Dr. Ali Azizzadeh discusses the outcomes of a trial to assess thoracic endovascular repair in blunt traumatic aortic injury.
Dr. Ali Azizzadeh discusses the outcomes of a trial to assess thoracic endovascular repair in blunt traumatic aortic injury.
Dr. Ali Azizzadeh discusses the...
06/10/2022
Vascular Disease Management
Dr. Riambau
LINC 2022
How Sac Regression at 1 Year Affects All-Cause Mortality Through 8 Years: Key Insights From the ENGAGE Registry
06/09/2022
Presented by Vicente Riambau, MD. 
Presented by Vicente Riambau, MD. 
Presented by Vicente Riambau,...
06/09/2022
Vascular Disease Management
Dr. Marc van Sambeek
LINC 2022
EXCeL Registry Post-Market Study on Angulated Necks
06/09/2022
The latest results from the important EXCeL registry by Marc van Sambeek, MD.
The latest results from the important EXCeL registry by Marc van Sambeek, MD.
The latest results from the...
06/09/2022
Vascular Disease Management
Drs. Montero-Baker and Somerset
LINC 2022
Ultrasound-based Calcium Score for the Identification of No-Option CLTI
06/09/2022
Dr. Miguel Montero-Baker and Dr. Jill Somerset introduce a study to correlate and validate a proposed scoring system for early identification of patients at risk for reinterventions.
Dr. Miguel Montero-Baker and Dr. Jill Somerset introduce a study to correlate and validate a proposed scoring system for early identification of patients at risk for reinterventions.
Dr. Miguel Montero-Baker and Dr....
06/09/2022
Vascular Disease Management
Dr. Gebauer
LINC 2022
DRAGON Investigates Double Venous Embolization
06/09/2022
Results from the DRAGON 1 trial were discussed on Tuesday, June 7,  by Bernhard Gebauer, MD, an interventional radiologist at the Charité University Hospital in Berlin, Germany.
Results from the DRAGON 1 trial were discussed on Tuesday, June 7,  by Bernhard Gebauer, MD, an interventional radiologist at the Charité University Hospital in Berlin, Germany.
Results from the DRAGON 1 trial...
06/09/2022
Vascular Disease Management
Dr. Mestres
LINC 2022
Cephalic Arch Stenosis Treatments Need Evidence
06/09/2022
Dr. Gaspar Mestres discusses cephalic arch stenosis, a controversial topic with controversial treatments.
Dr. Gaspar Mestres discusses cephalic arch stenosis, a controversial topic with controversial treatments.
Dr. Gaspar Mestres discusses...
06/09/2022
Vascular Disease Management
Dr. Steinbauer
LINC 2022
CERAB Emerges as the Aortoiliac Favorite
06/09/2022
Dr. Markus Steinbauer discusses the use of covered stents in complex aortoiliac peripheral artery occlusive disease lesions.
Dr. Markus Steinbauer discusses the use of covered stents in complex aortoiliac peripheral artery occlusive disease lesions.
Dr. Markus Steinbauer discusses...
06/09/2022
Vascular Disease Management
Dr. Goueffic
LINC 2022
EMINENT DES vs BMS trial: 12-month Primary Endpoint Data and Subset Analysis
06/09/2022
Dr. Yann Gouëffic presented included 1-year results from the EMINENT trial of 775 patients, making it the largest randomized industrial trial of a drug-eluting stent for the treatment of peripheral arterial disease to date.
Dr. Yann Gouëffic presented included 1-year results from the EMINENT trial of 775 patients, making it the largest randomized industrial trial of a drug-eluting stent for the treatment of peripheral arterial disease to date.
Dr. Yann Gouëffic presented...
06/09/2022
Vascular Disease Management
Primary Endpoint Outcomes
First-Time Data Release/LINC 2022
Abre 24-Month Study Outcomes and Subgroup Analyses
06/08/2022
Erin Murphy, MD, from Sanger Heart & Vascular Institute in Charlotte, North Carolina, shared the results of a study to evaluate the safety and effectiveness of the Abre venous self-expanding stent system (Medtronic) for treatment of...
Erin Murphy, MD, from Sanger Heart & Vascular Institute in Charlotte, North Carolina, shared the results of a study to evaluate the safety and effectiveness of the Abre venous self-expanding stent system (Medtronic) for treatment of...
Erin Murphy, MD, from Sanger...
06/08/2022
Vascular Disease Management
Study results
First-Time Data Release/LINC 2022
Cost-effectiveness of Urea Excipient-based Drug-coated Balloons for Chronic Limb-Threatening Ischemia From Femoropopliteal Disease
06/08/2022
Dr. Michel Reijnen presents the results of a study to assess the potential cost-effectiveness of drug-coated balloon use vs standard-of-care interventions in the Dutch and German healthcare systems.
Dr. Michel Reijnen presents the results of a study to assess the potential cost-effectiveness of drug-coated balloon use vs standard-of-care interventions in the Dutch and German healthcare systems.
Dr. Michel Reijnen presents the...
06/08/2022
Vascular Disease Management
Dr. Peter Schneider
LINC 2022
Exploring the Role of Transcarotid Artery Revascularization in Treating Carotid Stenosis
06/07/2022
Dr. Peter Schneider discusses his presentation on clinical insights on the use of transcarotid artery revascularisation (TCAR) for treating carotid artery stenosis at LINC 2022.
Dr. Peter Schneider discusses his presentation on clinical insights on the use of transcarotid artery revascularisation (TCAR) for treating carotid artery stenosis at LINC 2022.
Dr. Peter Schneider discusses...
06/07/2022
Vascular Disease Management
Dr. Richard Bulbulia
LINC 2022
Insights From the Two Largest Trials on Asymptomatic Carotid Stenosis
06/07/2022
Dr. Richard Bulbulia discusses his LINC 2022 presentation, "Asymptomatic Carotid Stenosis Treatment: Lessons From >600 Randomized Patients in AST 1 and 2."
Dr. Richard Bulbulia discusses his LINC 2022 presentation, "Asymptomatic Carotid Stenosis Treatment: Lessons From >600 Randomized Patients in AST 1 and 2."
Dr. Richard Bulbulia discusses...
06/07/2022
Vascular Disease Management
Study Overview
First-Time Data Release/LINC 2022
Long-term Evidence of Directional Atherectomy and DCB: 3-Year Clinical Experience from Australia
06/07/2022
Dr. VIkram Puttaswamy discusses the results of a 3-year clinical study of long-term use of directional atherectomy and drug-coated balloons.
Dr. VIkram Puttaswamy discusses the results of a 3-year clinical study of long-term use of directional atherectomy and drug-coated balloons.
Dr. VIkram Puttaswamy discusses...
06/07/2022
Vascular Disease Management
UltraScore Study Results
First-Time Data Release/LINC 2022
UltraScore: Final Results of a Multi-Center Study
06/07/2022
Dr. Robert Beasley discusses the results of a 12-month study of the clinical use of the UltraScore balloon in a real-world, on-label, clinical application.
Dr. Robert Beasley discusses the results of a 12-month study of the clinical use of the UltraScore balloon in a real-world, on-label, clinical application.
Dr. Robert Beasley discusses the...
06/07/2022
Vascular Disease Management
Hear from Prof Andrej Schmidt of Leipzig Universitätsklinikum on using Intelligent Guidance in Endovascular Interventions
Videos
Hear from Prof Andrej Schmidt of Leipzig Universitätsklinikum on using Intelligent Guidance in Endovascular Interventions
04/07/2020
Andrej Schmidt, MD (Sponsored by Cydar Medical)
Andrej Schmidt, MD (Sponsored by Cydar Medical)
Andrej Schmidt, MD (Sponsored...
04/07/2020
Vascular Disease Management
The COMPARE Trial: High- vs Low-Dose Drug-Coated Balloons
Videos
The COMPARE Trial: High- vs Low-Dose Drug-Coated Balloons
03/14/2020
Prof. Dierk Scheinert
Prof. Dierk Scheinert
Prof. Dierk Scheinert
03/14/2020
Vascular Disease Management
A Discussion of Tibial-Pedal Intervention
Videos
A Discussion of Tibial-Pedal Intervention
03/14/2020
John Rundback, MD
John Rundback, MD
John Rundback, MD
03/14/2020
Vascular Disease Management
5-Year Results From the ABSORB BTK Study: Bioresorbable Scaffolds for the Treatment of Tibial Artery Stenosis
Videos
5-Year Results From the ABSORB BTK Study: Bioresorbable Scaffolds for the Treatment of Tibial Artery Stenosis
03/14/2020
Ramon Varcoe, MBBS, MS, PhD
Ramon Varcoe, MBBS, MS, PhD
Ramon Varcoe, MBBS, MS, PhD
03/14/2020
Vascular Disease Management
Endovascular Aneurysm Repair (EVAR): "Keeping the Door Open" for the Next Intervention
Videos
Endovascular Aneurysm Repair (EVAR): "Keeping the Door Open" for the Next Intervention
03/14/2020
Eric Ducasse, MD, PhD
Eric Ducasse, MD, PhD
Eric Ducasse, MD, PhD
03/14/2020
Vascular Disease Management
Distal Puncture in Below-the-Knee Chronic Total Occlusions
Videos
Distal Puncture in Below-the-Knee Chronic Total Occlusions
03/14/2020
Hiroshi Ando, MD
Hiroshi Ando, MD
Hiroshi Ando, MD
03/14/2020
Vascular Disease Management
Duplex Scan as Sole Imaging Technique
Videos
Duplex Scan as Sole Imaging Technique
03/14/2020
Enrico Ascher, MD
Enrico Ascher, MD
Enrico Ascher, MD
03/14/2020
Vascular Disease Management
Ouriel: In-Depth Independent Safety Analysis by Syntactx (CRO) of the Lutonix SFA DCB Study
Videos
Ouriel: In-Depth Independent Safety Analysis by Syntactx (CRO) of the Lutonix SFA DCB Study
02/28/2020
Kenneth Ouriel, MD, MBA
Kenneth Ouriel, MD, MBA
Kenneth Ouriel, MD, MBA
02/28/2020
Vascular Disease Management
Clerici: Managing Wounds and Post PVA Care – Pearls From a Wound Care Specialist
Videos
Clerici: Managing Wounds and Post PVA Care – Pearls From a Wound Care Specialist
02/28/2020
Giacomo Clerici, MD
Giacomo Clerici, MD
Giacomo Clerici, MD
02/28/2020
Vascular Disease Management
Kölbel: Stroke in TEVAR
Videos
Kölbel: Stroke in TEVAR
02/28/2020
Tilo Kölbel, MD
Tilo Kölbel, MD
Tilo Kölbel, MD
02/28/2020
Vascular Disease Management
Gray: Paclitaxel and the Mortality Signal
Videos
Gray: Paclitaxel and the Mortality Signal
02/28/2020
William Gray, MD
William Gray, MD
William Gray, MD
02/28/2020
Vascular Disease Management
Parikh: Options for Femoral Popliteal Intervention
Videos
Parikh: Options for Femoral Popliteal Intervention
02/27/2020
Sahil Parikh, MD
Sahil Parikh, MD
Sahil Parikh, MD
02/27/2020
Vascular Disease Management
From the Founder: About the Leipzig Interventional Course (LINC)
Videos
From the Founder: About the Leipzig Interventional Course (LINC)
02/27/2020
Dierk Scheinert, MD
Dierk Scheinert, MD
Dierk Scheinert, MD
02/27/2020
Vascular Disease Management
First large randomized trial compares open bypass surgery to endovascular treatment of femoropopliteal lesions
Symposia
First large randomized trial compares open bypass surgery to endovascular treatment of femoropopliteal lesions
02/26/2020
Dr. Marc Bosiers, principal investigator, reports on 2-year results of the ZILVERPASS trial. Watch the video.
Dr. Marc Bosiers, principal investigator, reports on 2-year results of the ZILVERPASS trial. Watch the video.
Dr. Marc Bosiers, principal...
02/26/2020
Vascular Disease Management
Varcoe: New Meta-Analysis Shows No Difference in Mortality with Paclitaxel Coated vs Uncoated Devices in Patients with CLI
Symposia
Varcoe: New Meta-Analysis Shows No Difference in Mortality with Paclitaxel Coated vs Uncoated Devices in Patients with CLI
02/24/2020
Ramon L. Varcoe, MBBS, MS, FRACS, PhD
Ramon L. Varcoe, MBBS, MS, FRACS, PhD
Ramon L. Varcoe, MBBS, MS,...
02/24/2020
Vascular Disease Management
Discussing Paclitaxel Safety Data
Discussing Paclitaxel Safety Data
01/30/2020
Dierk Scheinert, MD
Dierk Scheinert, MD
Dierk Scheinert, MD
01/30/2020
Vascular Disease Management
When and How to Treat Patients With Genetic Aortic Disorders by Endovascular Aortic Techniques
Meeting Exclusives
When and How to Treat Patients With Genetic Aortic Disorders by Endovascular Aortic Techniques
01/30/2020
Tilo Kölbel, MD (German Aortic Centre, University Heart Centre Hamburg, Germany) questions the dogma that rejects the use of endovascular treatment of connective tissue disorders, during a session on the latest techniques for endovascular...
Tilo Kölbel, MD (German Aortic Centre, University Heart Centre Hamburg, Germany) questions the dogma that rejects the use of endovascular treatment of connective tissue disorders, during a session on the latest techniques for endovascular...
Tilo Kölbel, MD (German Aortic...
01/30/2020
Vascular Disease Management
Pave-and-Crack Technique Update at Seven Years
Meeting Exclusives
Pave-and-Crack Technique Update at Seven Years
01/30/2020
A novel endovascular strategy to target severe calcified occlusions, the so-called “pave-and-crack” technique, was the focus of a presentation by Manuela Matschuck, MD, from University Hospital Leipzig.
A novel endovascular strategy to target severe calcified occlusions, the so-called “pave-and-crack” technique, was the focus of a presentation by Manuela Matschuck, MD, from University Hospital Leipzig.
A novel endovascular strategy to...
01/30/2020
Vascular Disease Management
A Word of Warning on Lysis Therapy
Meeting Exclusives
A Word of Warning on Lysis Therapy
01/30/2020
“Catheter-directed intra-arterial thrombolysis is a rational and well-used method for therapy of chronic limb ischemia (CLI) patients with thrombotic occlusions of lower extremity arteries or bypass grafts,” said Ulrich Beschorner, MD.
“Catheter-directed intra-arterial thrombolysis is a rational and well-used method for therapy of chronic limb ischemia (CLI) patients with thrombotic occlusions of lower extremity arteries or bypass grafts,” said Ulrich Beschorner, MD.
“Catheter-directed...
01/30/2020
Vascular Disease Management
Scallops May Offer a Simple Alternative to Branched Devices in the Arch
Meeting Exclusives
Scallops May Offer a Simple Alternative to Branched Devices in the Arch
01/30/2020
Results of the first European prospective, multicenter clinical study of the use of a proximal scallop endograft that accommodates the supraaortic trunks were presented by Jean-Marc Alsac, MD.
Results of the first European prospective, multicenter clinical study of the use of a proximal scallop endograft that accommodates the supraaortic trunks were presented by Jean-Marc Alsac, MD.
Results of the first European...
01/30/2020
Vascular Disease Management
‘Incredible Efficacy’ of DES Treatment of Long BTK Lesions
Presentation
‘Incredible Efficacy’ of DES Treatment of Long BTK Lesions
01/30/2020
Robert Lookstein, MD (Icahn School of Medicine at Mount Sinai, New York City) presented 10-year findings of the LONG DES-BTK study of the use of drug-eluting stents (DES) in the treatment of BTK disease.
Robert Lookstein, MD (Icahn School of Medicine at Mount Sinai, New York City) presented 10-year findings of the LONG DES-BTK study of the use of drug-eluting stents (DES) in the treatment of BTK disease.
Robert Lookstein, MD (Icahn...
01/30/2020
Vascular Disease Management
DETOUR Into Long Lesions: A Viable Alternative to Open Fem-Pop Surgery
Meeting Exclusives
DETOUR Into Long Lesions: A Viable Alternative to Open Fem-Pop Surgery
01/30/2020
Peter Schneider, MD, discussed the latest investigational device exemption (IDE) study of the DETOUR System, dubbed the US IDE DETOUR II Clinical Trial, which is currently recruiting across 37 sites in the U.S., Germany, Poland, and Latvia.
Peter Schneider, MD, discussed the latest investigational device exemption (IDE) study of the DETOUR System, dubbed the US IDE DETOUR II Clinical Trial, which is currently recruiting across 37 sites in the U.S., Germany, Poland, and Latvia.
Peter Schneider, MD, discussed...
01/30/2020
Vascular Disease Management
The COMPARE Trial: 12-Month Results
Symposia
The COMPARE Trial: 12-Month Results
01/30/2020
A discussion of the COMPARE trial 12-month data, presented for the first time by Sabine Steiner, MD.
A discussion of the COMPARE trial 12-month data, presented for the first time by Sabine Steiner, MD.
A discussion of the COMPARE...
01/30/2020
Vascular Disease Management
LINC 2020 Session: Latest Insights on the Safety and Efficacy of Drug-Coated Devices
Videos
LINC 2020 Session: Latest Insights on the Safety and Efficacy of Drug-Coated Devices
01/30/2020
Dierk Scheinert, MD, and Bill Gray, MD, moderate this LINC 2020 session focusing on paclitaxel safety and with several new data releases. Featured are presentations by Drs Holden, Ouriel, Schneider, Guo, Zeller, Freisinger, and Gray.
Dierk Scheinert, MD, and Bill Gray, MD, moderate this LINC 2020 session focusing on paclitaxel safety and with several new data releases. Featured are presentations by Drs Holden, Ouriel, Schneider, Guo, Zeller, Freisinger, and Gray.
Dierk Scheinert, MD, and Bill...
01/30/2020
Vascular Disease Management
Two-Year Data on Percutaneous Deep Vein Arterialization: Findings From the ALPS Registry
Meeting Exclusives
Two-Year Data on Percutaneous Deep Vein Arterialization: Findings From the ALPS Registry
01/29/2020
(Leipzig, Germany) January 29, 2020 -- Two-year registry data on the LimFlow (LimFlow SA, France) percutaneous deep vein arterialization (pDVA) system were presented by Andrej Schmidt, MD (University Hospital Leipzig, Germany) in a first-time...
(Leipzig, Germany) January 29, 2020 -- Two-year registry data on the LimFlow (LimFlow SA, France) percutaneous deep vein arterialization (pDVA) system were presented by Andrej Schmidt, MD (University Hospital Leipzig, Germany) in a first-time...
(Leipzig, Germany) January 29,...
01/29/2020
Vascular Disease Management
The First 24-Month Data Release on the BTK Global Real-World Registry of the Lutonix DCB
Meeting Exclusives
The First 24-Month Data Release on the BTK Global Real-World Registry of the Lutonix DCB
01/29/2020
Two-year results of the Lutonix registry were presented on Wednesday by Dierk Scheinert, MD, who is the study’s co-principal investigator alongside Michael Lichtenberg, MD.
Two-year results of the Lutonix registry were presented on Wednesday by Dierk Scheinert, MD, who is the study’s co-principal investigator alongside Michael Lichtenberg, MD.
Two-year results of the Lutonix...
01/29/2020
Vascular Disease Management
A Bright Future for Laser Atherectomy?
Meeting Exclusives
A Bright Future for Laser Atherectomy?
01/29/2020
(Leipzig, Germany) January 29, 2020 -- First-time data on ‘Advancing laser therapy: Different settings for different lesions’ was presented on Tuesday morning by George Adams, MD (University of North Carolina Medical Center, Raleigh, NC), who...
(Leipzig, Germany) January 29, 2020 -- First-time data on ‘Advancing laser therapy: Different settings for different lesions’ was presented on Tuesday morning by George Adams, MD (University of North Carolina Medical Center, Raleigh, NC), who...
(Leipzig, Germany) January 29,...
01/29/2020
Vascular Disease Management
Lutonix BTK Trial 12-Month Data Released
Meeting Exclusives
Lutonix BTK Trial 12-Month Data Released
01/29/2020
(Leipzig, Germany) January 29, 2020 -- Continuing the series of first-time data releases at LINC, Patrick J. Geraghty, MD (Washington University Medical School, and Barnes-Jewish Hospital in Saint Louis, MO) presented 12-month data of the...
(Leipzig, Germany) January 29, 2020 -- Continuing the series of first-time data releases at LINC, Patrick J. Geraghty, MD (Washington University Medical School, and Barnes-Jewish Hospital in Saint Louis, MO) presented 12-month data of the...
(Leipzig, Germany) January 29,...
01/29/2020
Vascular Disease Management
Elevated Venous Pressure
Videos
Special Focus: The Role of Elevated Venous Pressure in Venous Insufficiency
01/29/2020
Featuring Raghu Kolluri, MD, System Medical Director of Vascular Medicine, Riverside Methodist Hospital/ OhioHealth System, Columbus, Ohio.
Featuring Raghu Kolluri, MD, System Medical Director of Vascular Medicine, Riverside Methodist Hospital/ OhioHealth System, Columbus, Ohio.
Featuring Raghu Kolluri, MD,...
01/29/2020
Vascular Disease Management
12-Month Lutonix BTK IDE Trial Results Presented at LINC 2020
Videos
12-Month Lutonix BTK IDE Trial Results Presented at LINC 2020
01/29/2020
Featuring Patrick J. Geraghty, MD, Washington University Medical School, and Barnes-Jewish Hospital in Saint Louis, Missouri.
Featuring Patrick J. Geraghty, MD, Washington University Medical School, and Barnes-Jewish Hospital in Saint Louis, Missouri.
Featuring Patrick J. Geraghty,...
01/29/2020
Vascular Disease Management
News
BD Announces Long-Term Safety Data for Below-the-Knee Drug-Coated Balloon
01/29/2020
01/29/2020
Vascular Disease Management
One-Year Results From COMPARE Trial Presented at LINC
Meeting Exclusives
One-Year Results From COMPARE Trial Presented at LINC
01/28/2020
One-year results from the COMPARE trial were presented by Sabine Steiner, MD, on the first morning of LINC, shedding new light on the impact of high- vs low-dose paclitaxel dosing in drug-eluting balloon (DCB) treatment of femoropopliteal...
One-year results from the COMPARE trial were presented by Sabine Steiner, MD, on the first morning of LINC, shedding new light on the impact of high- vs low-dose paclitaxel dosing in drug-eluting balloon (DCB) treatment of femoropopliteal...
One-year results from the...
01/28/2020
Vascular Disease Management
Endo AV Access: New Data Emerge on the WavelinQ System
Meeting Exclusives
Endo AV Access: New Data Emerge on the WavelinQ System
01/28/2020
Rob Jones, MD, presented a first-time data release from the prospective, multicenter study to evaluate the WavelinQ endoAVF system (BD), used to create an endovascular arteriovenous fistula (endoAVF) for patients requiring vascular access for...
Rob Jones, MD, presented a first-time data release from the prospective, multicenter study to evaluate the WavelinQ endoAVF system (BD), used to create an endovascular arteriovenous fistula (endoAVF) for patients requiring vascular access for...
Rob Jones, MD, presented a...
01/28/2020
Vascular Disease Management
PERFORMANCE I Trial Reveals 100% Success, 0% Stroke for Novel 3-in-1 Neuroguard Device
Meeting Exclusives
PERFORMANCE I Trial Reveals 100% Success, 0% Stroke for Novel 3-in-1 Neuroguard Device
01/28/2020
Evaluating a novel 3-in-1 carotid stent, post-dilatation balloon, and embolic protection device.
Evaluating a novel 3-in-1 carotid stent, post-dilatation balloon, and embolic protection device.
Evaluating a novel 3-in-1...
01/28/2020
Vascular Disease Management
Pedal-Plantar Loop Techniques: Lessons From a Maestro
Meeting Exclusives
Pedal-Plantar Loop Techniques: Lessons From a Maestro
01/28/2020
Below-the-ankle revascularization and the pedal-plantar loop (PPL) technique was discussed by Marco Manzi, MD, Director of the Interventional Radiology Unit at Foot & Ankle Clinic of Policlinico Abano Terme (Padua, Italy).
Below-the-ankle revascularization and the pedal-plantar loop (PPL) technique was discussed by Marco Manzi, MD, Director of the Interventional Radiology Unit at Foot & Ankle Clinic of Policlinico Abano Terme (Padua, Italy).
Below-the-ankle...
01/28/2020
Vascular Disease Management
Independent Analysis of Lutonix DCB Data Reveals No Plausible Link Between Paclitaxel and Mortality
Meeting Exclusives
Independent Analysis of Lutonix DCB Data Reveals No Plausible Link Between Paclitaxel and Mortality
01/28/2020
Kenneth Ouriel, MD, presented the latest insights into the safety and efficacy of drug-coated devices took centre stage on Tuesday morning, with a large chunk of the session dedicated to paclitaxel safety.
Kenneth Ouriel, MD, presented the latest insights into the safety and efficacy of drug-coated devices took centre stage on Tuesday morning, with a large chunk of the session dedicated to paclitaxel safety.
Kenneth Ouriel, MD, presented...
01/28/2020
Vascular Disease Management
News
Four-Year Data From ILLUMENATE Pivotal Trial Reaffirms Safety Profile of Philips Stellarex Low-Dose Drug-Coated Balloon
01/27/2020
With mortality rates similar to standard of care through four years with excellent rate of follow-up compliance, Philips Stellarex is the only low-dose drug-coated balloon (DCB) to demonstrate sustained treatment effect and high safety...
With mortality rates similar to standard of care through four years with excellent rate of follow-up compliance, Philips Stellarex is the only low-dose drug-coated balloon (DCB) to demonstrate sustained treatment effect and high safety...
With mortality rates similar to...
01/27/2020
Vascular Disease Management

The LEIPZIG INTERVENTIONAL COURSE (LINC) is strongly committed to contribute to a systematic scientific evaluation and interdisciplinary discussion of new methods, allowing conclusions for daily interventional practice. LINC is an interdisciplinary live course, designed to provide a global platform, permitting the discussion of the "vascular patient“ by integrating colleagues of different specialties who are performing endovascular interventions. More about The Leipzig Interventional Course (LINC)

Stay in the Know

Vascular Disease Management Newsletter

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use